TPST

Tempest Agrees To Extend Limited Duration Stockholder Rights Plan

(RTTNews) - Tempest Therapeutics, Inc. (TPST), Thursday announced the decision to expand the duration of its existing stockholder rights plan till the Annual Meeting of Stockholders.

CEO Stephen Brady said the rights plan is intended to enable all stockholders to realize the long-term value of their investment. Further, it would reduce the likelihood that any person or group gains control of Tempest through open market accumulation.

Currently, Tempest's stock is trading at $1.36, up 1.41 percent on the Nasdaq.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.